Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 18/20 | 0.52 |
| ▸ | PRMT6 | Q96LA8 | 17/20 | 0.52 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.44 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.44 |
| ▸ | PRCP | P42785 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL768103 | 0.84 | HRH3 (0.41) | CARM1PRMT6PRCP | |
| SCHEMBL28896792 | 0.83 | KMT2A (0.50) | — | |
| SCHEMBL29277149 | 0.80 | CARM1 (0.50) | CARM1PRMT6TLR9PRMT3PRMT8 | |
| SCHEMBL768953 | 0.79 | HRH3 (0.42) | PRCP | |
| SCHEMBL768111 | 0.79 | CHRM2 (0.43) | CARM1PRMT6PRMT8 | |
| SCHEMBL769138 | 0.78 | HRH3 (0.41) | PRCP | |
| SCHEMBL768533 | 0.78 | HRH3 (0.41) | PRCP | |
| SCHEMBL767767 | 0.78 | HRH3 (0.41) | PRCP | |
| SCHEMBL769143 | 0.77 | CHRM2 (0.40) | CARM1PRMT6PRMT8PRCP | |
| Hydrochloric Acid SCHEMBL768805 | 0.77 | CHRM3 (0.45) | PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071467-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071467-A1 | AMIDE DERIVATIVE | CHRM3, CHRM2, TACR2 | CARM1 1411/4885PRMT6 1142/4885TLR9 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.